What is the role of androgen deprivation therapy (ADT) in prostate cancer treatment? In this episode of the BackTable Urology Podcast, Dr. Rana McKay, a medical oncologist from UC San Diego, joins host Dr. Aditya Bagrodia to discuss the administration of ADT and other management strategies for prostate cancer.

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

The doctors offer a historical perspective into the evolution of ADT over time and discuss the variety of different ADT treatment options available. They compare management strategies for localized and metastatic prostate cancer and discuss how to align therapy with patient goals, focusing on the side effects. The conversation also explores the impact of prostate-specific membrane antigen (PSMA) PET imaging on management and the future directions of hormonal therapies in urologic oncology.

---

TIMESTAMPS

00:00 - Introduction

05:25 - ADT Options

10:36 - Choosing an Agent and Managing Side Effects

26:42 - Continuous Versus Intermittent Therapy

30:30 - Closing Remarks

---

RESOURCES

Photocure

https://www.photocure.com/

Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay